Tempest Therapeutics, Inc.
TPST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001544227
No open-market purchases or sales by Tempest Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.44M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Tempest Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 32 | 30 | −2 |
| Shares | 2.21M | 1.86M | −348.9K (−15.8%) |
| Value | $9.74M | $7.29M | −$2.45M (−25.2%) |
New holders (5)
Institutions that held Tempest Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 21,036 | $82.3K | 0.00% |
| HRT Financial LP | 13,040 | $50.0K | 0.00% |
| XTX Topco Ltd | 10,773 | $42.1K | 0.01% |
| CIBC Private Wealth Group, LLC | 133 | $724 | 0.00% |
| Citadel Advisors LLC | 3 | $12 | 0.00% |
Sold out (7)
Institutions that held Tempest Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| EAM Investors, LLC | 140,300 | $617.3K |
| Two Sigma Investments, LP | 100,215 | $440.9K |
| Two Sigma Securities, LLC | 35,483 | $156.1K |
| Bank of New York Mellon Corp | 13,941 | $61.3K |
| Schonfeld Strategic Advisors LLC | 10,300 | $45.3K |
| MayTech Global Investments, LLC | 10,000 | $44.0K |
| JPMorgan Chase & Co | 110 | $484 |